RYHIX vs. FBIOX

Last updated Jun 24, 2026

RYHIX (Rydex Health Care Fund) and FBIOX (Fidelity Select Biotechnology Portfolio) are both Health & Biotech Equities funds. Over the past 10 years, RYHIX returned 8.85%/yr vs 11.69%/yr for FBIOX. A 0.78 correlation means they provide meaningful diversification when combined. RYHIX charges 1.35%/yr vs 0.69%/yr for FBIOX.

Performance

RYHIX vs. FBIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rydex Health Care Fund (RYHIX) and Fidelity Select Biotechnology Portfolio (FBIOX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RYHIX achieves a -0.37% return, which is significantly lower than FBIOX's 11.03% return. Over the past 10 years, RYHIX has underperformed FBIOX with an annualized return of 8.85%, while FBIOX has yielded a comparatively higher 11.69% annualized return.

RYHIX

• 1D: 0.48%
• 1M: 1.98%
• YTD: -0.37%
• 6M: -1.40%
• 1Y: 16.10%
• 3Y*: 6.13%
• 5Y*: 2.93%
• 10Y*: 8.85%

FBIOX

• 1D: 2.80%
• 1M: 6.82%
• YTD: 11.03%
• 6M: 8.61%
• 1Y: 58.91%
• 3Y*: 20.04%
• 5Y*: 6.76%
• 10Y*: 11.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RYHIX vs. FBIOX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RYHIX Rydex Health Care Fund	-0.37%	14.42%	0.61%	5.84%	-11.59%	19.27%	18.84%	22.77%	1.56%	23.48%
FBIOX Fidelity Select Biotechnology Portfolio	11.03%	36.38%	7.26%	10.09%	-15.87%	-12.26%	38.62%	36.12%	-10.92%	27.87%

Correlation

The correlation between RYHIX and FBIOX is 0.73, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.73
Correlation (3Y) Calculated over the trailing 3-year period	0.75
Correlation (5Y) Calculated over the trailing 5-year period	0.75
Correlation (10Y) Calculated over the trailing 10-year period	0.80
Correlation (All Time) Calculated using the full available price history since Jan 4, 1999	0.78

The correlation between RYHIX and FBIOX has been stable across timeframes, ranging from 0.73 to 0.80 - a consistent structural relationship.

Return for Risk

RYHIX vs. FBIOX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RYHIX

RYHIX Risk / Return Rank: 17
RYHIX Sharpe Ratio Rank: 17
RYHIX Sortino Ratio Rank: 18
RYHIX Omega Ratio Rank: 16
RYHIX Calmar Ratio Rank: 18
RYHIX Martin Ratio Rank: 15

FBIOX

FBIOX Risk / Return Rank: 88
FBIOX Sharpe Ratio Rank: 90
FBIOX Sortino Ratio Rank: 84
FBIOX Omega Ratio Rank: 73
FBIOX Calmar Ratio Rank: 98
FBIOX Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RYHIX vs. FBIOX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rydex Health Care Fund (RYHIX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RYHIX	FBIOX	Difference
Sharpe ratio: Return per unit of total volatility	1.07	2.74	-1.67
Sortino ratio: Return per unit of downside risk	1.65	3.65	-2.00
Omega ratio: Gain probability vs. loss probability	1.19	1.44	-0.25
Calmar ratio: Return relative to maximum drawdown	1.41	7.66	-6.25
Martin ratio: Return relative to average drawdown	3.82	23.32	-19.50

RYHIX vs. FBIOX - Sharpe Ratio Comparison

The current RYHIX Sharpe Ratio is 1.07, which is lower than the FBIOX Sharpe Ratio of 2.74. The chart below compares the historical Sharpe Ratios of RYHIX and FBIOX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RYHIX vs. FBIOX - Drawdown Comparison

The maximum RYHIX drawdown since its inception was -41.27%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for RYHIX and FBIOX.

Drawdown Indicators

	RYHIX	FBIOX	Difference
Max Drawdown Largest peak-to-trough decline	-41.27%	-71.98%	+30.71%
Max Drawdown (1Y) Largest decline over 1 year	-11.31%	-7.62%	-3.69%
Max Drawdown (3Y) Largest decline over 3 years	-17.46%	-27.83%	+10.37%
Max Drawdown (5Y) Largest decline over 5 years	-22.83%	-44.87%	+22.04%
Max Drawdown (10Y) Largest decline over 10 years	-29.03%	-48.66%	+19.63%
Current Drawdown Current decline from peak	-4.13%	0.00%	-4.13%
Average Drawdown Average peak-to-trough decline	-8.65%	-23.60%	+14.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.17%	2.50%	+1.67%

Volatility

RYHIX vs. FBIOX - Volatility Comparison

The current volatility for Rydex Health Care Fund (RYHIX) is 4.92%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 8.04%. This indicates that RYHIX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RYHIX	FBIOX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.92%	8.04%	-3.12%
Volatility (6M) Calculated over the trailing 6-month period	10.83%	17.08%	-6.25%
Volatility (1Y) Calculated over the trailing 1-year period	15.03%	21.36%	-6.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.85%	25.03%	-9.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.65%	26.26%	-8.61%

RYHIX vs. FBIOX - Expense Ratio Comparison

RYHIX has a 1.35% expense ratio, which is higher than FBIOX's 0.69% expense ratio.

Dividends

RYHIX vs. FBIOX - Dividend Comparison

RYHIX's dividend yield for the trailing twelve months is around 2.18%, less than FBIOX's 6.06% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBIOX Fidelity Select Biotechnology Portfolio	6.06%	2.47%	1.21%	0.45%	0.00%	14.48%	19.46%	8.89%	11.18%	1.41%	3.42%	6.71%
RYHIX Rydex Health Care Fund	2.18%	2.18%	0.00%	0.00%	1.64%	3.19%	8.81%	0.00%	1.76%	9.17%	13.88%	6.39%

Frequently Asked Questions

Can I hold both RYHIX and FBIOX in my portfolio?

RYHIX and FBIOX have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RYHIX or FBIOX?

FBIOX has higher volatility (8.04%) compared to RYHIX (4.92%). In terms of maximum drawdown, RYHIX dropped -41.27% vs FBIOX's -71.98%.

Which has better risk-adjusted returns?

FBIOX currently has the higher Sharpe Ratio (2.74 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.